Medios stock extends 2026 slide after profit guidance cut
Published on 08/29/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medios AG (ISIN DE000A1MMCC8) stock traded at EUR 10.90 on Tradegate as of August 27, 2026, after a 25.07 percent year-to-date decline and a 2.15 percent drop over the prior five trading days.
Guidance reset
The move follows a profit guidance cut announced on July 29, 2026, which has kept the share price well below its start-of-year level.
The contrast is stark: a single 2.15 percent five-day loss sits alongside a 25.07 percent slide since January 1, 2026. That gap shows how much of the rerating came after management changed the 2026 earnings outlook.
What the market is pricing
Medios shares now reflect a lower earnings base for 2026, with the market still marking down the stock even after the initial reaction passed.
For investors, the key figure is the EUR 10.90 Tradegate print on August 27, 2026, because it anchors the current valuation after the guidance revision.
Medios business mix
Medios supplies specialty pharmaceuticals and related services for pharmacies and clinics, with logistics and margin discipline central to the model.
That business profile matters more after a profit reset, because small changes in execution can have a visible effect on earnings and sentiment.
Medios shares at the late-August level
As of August 27, 2026, Medios shares were quoted at EUR 10.90 on Tradegate.
The stock's 25.07 percent decline in 2026 remains the clearest market signal around the name.
Fact box
Company: Medios AG
ISIN: DE000A1MMCC8
Ticker: ILM1
Exchange: Tradegate
Price (as of August 27, 2026): EUR 10.90
Sector / Industry: Healthcare services / specialty pharmaceuticals
